DENVER, July 9 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies, Inc.(R) (OTC:GLOB) (BULLETIN BOARD: GLOB) , announced today that Sarasota Memorial Hospital and Suncoast Communities Blood Bank have enhanced their partnership by using Wyndgate's blood bank management software. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Suncoast Communities Blood Bank in Sarasota, Florida, began using Wyndgate's SafeTrace(R) donor management system last year to help streamline business operations and help enhance patient safety. When Sarasota Memorial Hospital, one of Suncoast Communities' hospital clients, needed to upgrade its transfusion management system, the blood bank recommended Wyndgate's SafeTrace Tx(R) software. Suncoast Communities Blood Bank has been a customer of Wyndgate Technologies since it purchased its SafeTrace(R) blood bank management software in 2005. "The Wyndgate system has made it easier for us to comply with regulatory changes. Overall we have been satisfied with its performance and the benefits it has brought to our organization," remarked Dr. Mark Magenheim, CEO and Medical Director of Suncoast Communities Blood Bank. "When Sarasota Memorial Hospital needed a new computer system for its transfusion service, we implemented Wyndgate's SafeTrace Tx* transfusion management system. We know that these Wyndgate products are 510(k) cleared by the FDA and are confident of the products' quality." In addition to supplying a qualified system, Wyndgate's integrated products are enabling Sarasota Memorial Hospital and Suncoast Communities Blood Bank to boost their partnership to a new level. Wyndgate's SafeTrace and SafeTrace Tx products were designed as Vein-to-Vein(R) products offering seamless management of information from collection and manufacturing through final transfusion and billing. Communication and sharing of safety information will now be easier between the hospital and its blood source than ever before. "It is a notable benefit to both Sarasota Memorial Hospital and Suncoast Communities Blood Bank that SafeTrace and SafeTrace Tx are designed to integrate seamlessly. The reliable exchange of critical information between our systems will help us retain our high standards of patient safety," Dr. Magenheim stated. Thomas F. Marcinek, President and Chief Operating Officer for Wyndgate Technologies, commented, "The goal of Wyndgate's products is to help our customers improve their businesses so they may provide the best possible service to their patients and communities. Our Vein-to-Vein(R) products are designed to help donor centers and transfusion services easily manage and share important information as required by their businesses. We are very pleased that these products will help Sarasota Memorial Hospital and Suncoast Communities Blood Bank to strengthen and grow their relationship. We have enjoyed working with Suncoast Communities Blood Bank since 2005 and look forward to many years of continuing this work with Sarasota Memorial Hospital." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: company, Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or investors, Paul Holm of H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies, Inc. Web site: http://www.globalmedtech.com/

Copyright